Free Republic
Browse · Search
General/Chat
Topics · Post Article

Skip to comments.

Drug may prevent COVID-19 in exposed people within households, major trial finds
https://medicalxpress.com/ ^ | 3/12/2025 | by University of Virginia

Posted on 03/30/2025 10:29:42 AM PDT by bitt

An international clinical trial has identified a medication that can help prevent symptomatic COVID-19 in people exposed within households. The results could be particularly important for families where someone is at high risk of serious complications from the illness.

The drug, ensitrelvir, is already approved in Japan to treat mild to moderate COVID cases. The SCORPIO-PEP trial, however, has demonstrated that it also has the potential to protect against illness. Uninfected people who began taking the antiviral within 72 hours of symptoms first appearing in a household member were significantly less likely to contract COVID-19 than people who were given an inactive placebo.

Among the more than 2,000 trial participants in the United States and abroad, 9% of the participants taking the placebo developed confirmed cases of COVID-19. That's compared with only 2.9% of people taking ensitrelvir—a 67% reduction in risk of COVID-19 illness.

"In addition to vaccination, post-exposure prophylaxis with timely use of an oral antiviral would be a valuable way to help prevent COVID-19 illness in people who have been exposed, especially people at high risk for severe disease," said University of Virginia School of Medicine emeritus professor Frederick G. Hayden, MD, who helped design the trial and presented the trial results today at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.

Conducted between June 2023 and September 2024, the SCORPIO-PEP trial was double-blinded, meaning neither the researchers nor the uninfected household participants knew whether they were receiving ensitrelvir or placebo. Household members who took a 5-day course of ensitrelvir after exposure to a proven COVID illness were much less likely to get COVID but no more likely to suffer adverse events than those who took placebo.

(Excerpt) Read more at medicalxpress.com ...


TOPICS:
KEYWORDS: chinavirus; chinavirustreatment; covid19; ensitrelvir
Navigation: use the links below to view more comments.
first previous 1-2021-23 last
To: bitt

Nicotine.


21 posted on 03/30/2025 12:16:24 PM PDT by Disambiguator
[ Post Reply | Private Reply | To 1 | View Replies]

To: Pollard

Stick with the IVM


22 posted on 03/30/2025 1:48:49 PM PDT by ptsal (Vote R.E.D. >>>Remove Every Democrat ***)
[ Post Reply | Private Reply | To 3 | View Replies]

To: bitt

I’ve skipped the deadly clot shots & boosters and do NOT plan to change that winning strategy and remain a pure blood.


23 posted on 03/30/2025 1:51:29 PM PDT by newfreep ("There is no race problem...just a problem race")
[ Post Reply | Private Reply | To 1 | View Replies]


Navigation: use the links below to view more comments.
first previous 1-2021-23 last

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
General/Chat
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson